NIH #2P30CA016058-50
Project 05: Translational Therapeutics (TT)
Active
- Amount
- $68K
- Period
- 1997-09-12 → 2031-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5UG1CA233259-06
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
Active
- Amount
- $683K
- Period
- 2019-03-14 → 2027-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5R01CA248741-05
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
Active
- Amount
- $742K
- Period
- 2021-02-01 → 2027-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #3UG1CA233259-06S1
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
- Amount
- $683K
- Period
- 2025-01-02 → 2026-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #3UG1CA233331-06S1
OSU as a Network Lead Academic Participating Site for the NCI NCTN
- Amount
- $1.0M
- Period
- 2019-03-28 → 2026-02-28
- PIs
- 5
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5UG1CA233331-06
OSU as a Network Lead Academic Participating Site for the NCI NCTN
- Amount
- $1.3M
- Period
- 2019-03-28 → 2026-02-28
- PIs
- 5
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5R01CA248741-04
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
- Amount
- $705K
- Period
- 2021-02-01 → 2026-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5R01CA248741-03
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
- Amount
- $380K
- Period
- 2021-02-01 → 2026-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5R01CA248741-02
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
- Amount
- $560K
- Period
- 2021-02-01 → 2026-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #1R01CA248741-01A1
Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
- Amount
- $577K
- Period
- 2021-02-01 → 2026-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5P30CA016058-49
Project 05: Translational Therapeutics (TT)
- Amount
- $61K
- Period
- 1997-09-12 → 2025-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5P30CA016058-48
Project 05: Translational Therapeutics (TT)
- Amount
- $52K
- Period
- 1997-09-12 → 2025-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5P30CA016058-47
Project 05: Translational Therapeutics (TT)
- Amount
- $52K
- Period
- 1997-09-12 → 2025-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5P30CA016058-46
Project 05: Translational Therapeutics (TT)
- Amount
- $56K
- Period
- 1997-09-12 → 2025-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #2P30CA016058-45
Project 05: Translational Therapeutics (TT)
- Amount
- $62K
- Period
- 1997-09-12 → 2025-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5UG1CA233331-05
OSU as a Network Lead Academic Participating Site for the NCI NCTN
- Amount
- $968K
- Period
- 2019-03-28 → 2025-02-28
- PIs
- 5
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5UG1CA233259-05
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
- Amount
- $622K
- Period
- 2019-03-14 → 2025-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5UG1CA233259-04
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
- Amount
- $734K
- Period
- 2019-03-14 → 2025-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5UG1CA233331-04
OSU as a Network Lead Academic Participating Site for the NCI NCTN
- Amount
- $1.1M
- Period
- 2019-03-28 → 2025-02-28
- PIs
- 5
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5UG1CA233331-03
OSU as a Network Lead Academic Participating Site for the NCI NCTN
- Amount
- $1.2M
- Period
- 2019-03-28 → 2025-02-28
- PIs
- 5
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5UG1CA233259-03
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
- Amount
- $742K
- Period
- 2019-03-14 → 2025-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5UG1CA233331-02
OSU as a Network Lead Academic Participating Site for the NCI NCTN
- Amount
- $1.1M
- Period
- 2019-03-28 → 2025-02-28
- PIs
- 5
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5UG1CA233259-02
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
- Amount
- $751K
- Period
- 2019-03-14 → 2025-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #1UG1CA233259-01
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
- Amount
- $852K
- Period
- 2019-03-14 → 2025-02-28
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #1UG1CA233331-01
OSU as a Network Lead Academic Participating Site for the NCI NCTN
- Amount
- $1.1M
- Period
- 2019-03-28 → 2025-02-28
- PIs
- 5
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #2P30CA016058-40
Translational Therapeutics Research Program (TT)
- Amount
- $36K
- Period
- 1997-09-12 → 2020-11-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5R01CA175370-05
Notch ligands in regulation of anti-cancer immunity
- Amount
- $314K
- Period
- 2013-09-26 → 2019-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #4R01CA175370-04
Notch ligands in regulation of anti-cancer immunity
- Amount
- $314K
- Period
- 2013-09-26 → 2018-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5R01CA175370-02
Notch ligands in regulation of anti-cancer immunity
- Amount
- $305K
- Period
- 2013-09-26 → 2018-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #1R01CA175370-01A1
Notch ligands in regulation of anti-cancer immunity
- Amount
- $327K
- Period
- 2013-09-26 → 2018-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5R01CA175370-03
Notch ligands in regulation of anti-cancer immunity
- Amount
- $314K
- Period
- 2013-09-26 → 2016-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #1U54CA163072-01
Clinical Trials Core
- Amount
- $273K
- Period
- 2011-09-23 → 2016-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at VANDERBILT UNIVERSITY
NIH #5U54CA163072-05
Clinical Trials Core
- Amount
- $254K
- Period
- — → 2016-04-29
- PIs
- 2
- Est. capacity / PI
- ~2 students
Awarded at VANDERBILT UNIVERSITY
NIH #7RC1CA146260-03
Polymorphism and mutation spectrum in minorities with non-small cell lung cancer
- Amount
- $186K
- Period
- 2009-09-30 → 2013-09-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5P50CA090949-10
DEVELOPMENTAL RESEARCH PROGRAM
- Amount
- $64K
- Period
- — → 2013-03-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at VANDERBILT UNIVERSITY
NIH #5RC1CA146260-02
Polymorphism and mutation spectrum in minorities with non-small cell lung cancer
- Amount
- $311K
- Period
- 2009-09-30 → 2012-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at VANDERBILT UNIVERSITY
NIH #5P50CA090949-09
SPORE in Lung Cancer
- Amount
- $2.3M
- Period
- 2001-06-28 → 2012-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at VANDERBILT UNIVERSITY
NIH #5P30CA016058-44
Translational Therapeutics Research Program (TT)
- Amount
- $49K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5P30CA016058-43
Translational Therapeutics Research Program (TT)
- Amount
- $53K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #3P30CA016058-42S3
Translational Therapeutics Research Program (TT)
- Amount
- $2K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #3P30CA016058-42S2
Translational Therapeutics Research Program (TT)
- Amount
- $2K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5P30CA016058-42
Translational Therapeutics Research Program (TT)
- Amount
- $66K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at OHIO STATE UNIVERSITY
NIH #3P30CA016058-42S1
Translational Therapeutics Research Program (TT)
- Amount
- $2K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #3P30CA016058-42S4
Translational Therapeutics Research Program (TT)
- Amount
- $5K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5P30CA016058-41
Translational Therapeutics Research Program (TT)
- Amount
- $46K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at OHIO STATE UNIVERSITY
NIH #5U54CA163072-04
Clinical Trials Core
- Amount
- $255K
- Period
- — → —
- PIs
- 2
- Est. capacity / PI
- ~2 students
Awarded at VANDERBILT UNIVERSITY
NIH #5U54CA163072-03
Clinical Trials Core
- Amount
- $238K
- Period
- — → —
- PIs
- 2
- Est. capacity / PI
- ~1 students
Awarded at VANDERBILT UNIVERSITY
NIH #5U54CA163072-02
Clinical Trials Core
- Amount
- $254K
- Period
- — → —
- PIs
- 2
- Est. capacity / PI
- ~2 students
Awarded at VANDERBILT UNIVERSITY